Publicaciones en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (10)

2021

  1. Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  2. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  3. PDCD4 limits prooncogenic neuregulin-ErbB signaling

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 4, pp. 1799-1815

2020

  1. Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 3117-3127

2019

  1. Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2018

  1. The immunoglobulin-like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation

    Molecular Oncology, Vol. 12, Núm. 7, pp. 1061-1076

2015

  1. Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors

    Oncotarget, Vol. 6, Núm. 31, pp. 31272-31283

2014

  1. Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling

    BMC Cancer, Vol. 14, Núm. 1

2009

  1. DNA DSBs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

    CLINICAL LYMPHOMA & MYELOMA

2000

  1. Stimulation of cleavage of membrane proteins by calmodulin inhibitors

    Biochemical Journal, Vol. 346, Núm. 2, pp. 359-367